Dementia Today.net

Site updated at Wednesday, 22 June 2016

Living with Dementia

Latrepirdine

No Benefit for Dimebon in Huntington’s

An antihistamine that failed to work in Alzheimer’s disease also fell short of expectations in Huntington’s disease, researchers reported.

In a randomized controlled trial, latrepirdine (Dimebon) didn’t improve cognition or global function compared with placebo, Ray Dorsey, MD, of Johns Hopkins, and colleagues reported online in the Archives of Neurology.

Currently, medications can mitigate… No Benefit for Dimebon in Huntington’s   



I have Alzheimer Disease

atrial fibrillation1 - alzheimer's risk4 - peanut butter1 - haldol1 - tetrahydrocannabinol1 - dementias first signs1 - long-term dementia1 - mini-strokes2 - dementia friends1 - a-beta protein1 - baroness thatcher1 - amyloid-targeting treatment1 - dsm iv3 - gastrointestinal disorders1 - cognitive enhancement1 - hypertension3 - cognitive tests1 - neuropathology of ad1 - menopause1 - 1 - postoperative cognitive dysfunction1 - huntington’s disease2 - memory losses1 - heart attack2 - lucretius1 - hippocampal atrophy1 - berrios2 - restlessness1 - hiv1 - amyloid-beta4 -